Dendreon Corp. buy melinda
Start price
06.09.10
/
50%
€31.33
Target price
07.03.11
€35.00
Performance (%)
-25.53%
End price
07.03.11
€23.33
Summary
This prediction ended on 07.03.11 with a price of €23.33. The prediction for Dendreon Corp. disappointed with a performance of -25.53%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dendreon Corp. | - | - | - | - |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% | 61.658% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% | 104.644% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% | 51.355% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% | 66.527% |
Comments by melinda for this prediction
In the thread Dendreon Corp. diskutieren
Biotechnologie
Dendreon Corp ist ein Unternehmen, über die Ausrichtung biotecnologie Krebs konzentriert, entwickelt und vermarktet neue Therapien
(Laufzeit überschritten)